Fig. 2
From: Osteopontin splice variants are differential predictors of breast cancer treatment responses
Kaplan-Meier survival curves for patients undergoing chemotherapy. Survival of patients under chemotherapy, distinguished according to low (0–1, diamonds) versus high (2–3, triangles) immunohistochemical markers. Shown are Kaplan Meier curves for osteopontin-c (top panel) or exon 4 (middle panel). For comparison, the survival of all patients treated (gray markers) or not treated (black markers) with chemotherapy is displayed (bottom panel). The x-axis indicates years since diagnosis, the y-axis reflects % surviving patients